Stock dips from a public share offering

When a company announces a public offering of common stock such as RITHM Capital has this week, it typically results in a temporary dip in its stock price for several reasons. First, the increase in the number of available shares leads to dilution, where each shareholder’s percentage ownership in the company decreases, thus reducing the…

Read More

REFI: A Cannabis Market Outlier

Most stocks that are in cannabis are struggling yet REFI is knocking it out of the park and Wall Street loves it!   This is an example how a performing dividend yield company can weather the storms even if an entire sector is being beaten down. See the article on Yahoo Delivering Returns As The…

Read More

Arcus Biosciences obtains $250m loan facility with Hercules Capital

The recent loan facility secured by Arcus Biosciences from Hercules Capital is strategically advantageous for both companies. Arcus Biosciences benefits significantly from this arrangement as it provides them with up to $200 million in funding, crucial for advancing their research and development initiatives, particularly in the costly and high-stakes biopharmaceutical industry. Importantly, this loan represents…

Read More

Dividend Stocks as a Hot Play

With the Federal Reserve’s interest rate decision approaching in September, more investors are eyeing dividend stocks. Experts believe that dividend stocks could be a strong play into the fall, providing a stable income stream amid market uncertainties.   Paul Baiocchi of SS&C ALPS Advisors supports this strategy, noting a shift from money markets and fixed…

Read More